Related Experiment Video
Updated: Sep 3, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Advanced therapy medicinal products]
Rasmus Roost Aabling1,2,3, Anne Louise Schacht Revenfeld4, Maria Rusan3,5,6,7
1Institut for Klinisk Medicin, Comparative Medicine Lab, Aarhus Universitet.
Abstract:
Advanced therapy medicinal products are a rapidly expanding drug class based on genes, cells, and tissues, transforming the treatment of diseases, including haematologic cancers and genetic disorders, such as sickle cell disease and haemophilia. This review highlights that successful clinical implementation requires coordinated national strategies, regulatory support, sustainable funding, robust clinical and production infrastructure, and trained specialised personnel to ensure timely, safe, and equitable patient access.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
FDA Approved Drugs: Changes to Approved Drugs
Therapeutic Drug Monitoring: Overview and Classification
Microorganisms in Medicine and Therapeutics
Drug Products: Biologics, Biosimilars and Interchangeables
Therapeutic Drug Monitoring: Affecting Factors
